Features Screener Stocks Charts
Sign In Sign Up

Dishman Pharmaceuticals & Chemicals Cash Flow Statement

NSE:DISHMAN | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

0.98x

DISHMAN's operating cash flow covered 98% of net income in FY 2018. Some earnings may be tied up in working capital.

Free Cash Flow

₹99.90M

DISHMAN's free cash flow was ₹99.90M in FY 2018, down 93.5% from FY 2017.

CapEx Intensity

95.6%

Capital expenditure consumed 95.6% of operating cash flow in FY 2018 for DISHMAN, typical of capital-intensive industries.

2-year DISHMAN cash flow snapshot

Hover the chart icon for YoY change.

FY 2017 - FY 2018
Item Chart 2017 2018
Net Income 2.16B 2.31B
Cash flow Operating Activities 3.03B 2.26B
Investments in PPE -1.48B -2.16B
Cash flow Investing Activities -1.42B -2.97B
Dividend Paid -193.70M 0
Cash flow Financing Activities -1.37B 776.20M
Cash at beginning of period 348.00M 586.10M
Cash at end of period 586.10M 655.20M
Free Cash Flow 1.55B 99.90M

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2018